Literature DB >> 9384603

Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease.

A G Bijvoet1, E H van de Kamp, M A Kroos, J H Ding, B Z Yang, P Visser, C E Bakker, M P Verbeet, B A Oostra, A J Reuser, A T van der Ploeg.   

Abstract

Glycogen storage disease type II (GSDII; Pompe disease), caused by inherited deficiency of acid alpha-glucosidase, is a lysosomal disorder affecting heart and skeletal muscles. A mouse model of this disease was obtained by targeted disruption of the murine acid alpha-glucosidase gene (Gaa) in embryonic stem cells. Homozygous knockout mice (Gaa -/-) lack Gaa mRNA and have a virtually complete acid alpha-glucosidase deficiency. Glycogen-containing lysosomes are detected soon after birth in liver, heart and skeletal muscle cells. By 13 weeks of age, large focal deposits of glycogen have formed. Vacuolar spaces stain positive for acid phosphatase as a sign of lysosomal pathology. Both male and female knockout mice are fertile and can be intercrossed to produce progeny. The first born knockout mice are at present 9 months old. Overt clinical symptoms are still absent, but the heart is typically enlarged and the electrocardiogram is abnormal. The mouse model will help greatly to understand the pathogenic mechanism of GSDII and is a valuable instrument to explore the efficacy of different therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9384603     DOI: 10.1093/hmg/7.1.53

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  37 in total

1.  A modified PAS stain combined with immunofluorescence for quantitative analyses of glycogen in muscle sections.

Authors:  Gert Schaart; Reinout P Hesselink; Hans A Keizer; Gerrit van Kranenburg; Maarten R Drost; Matthijs K C Hesselink
Journal:  Histochem Cell Biol       Date:  2004-08-03       Impact factor: 4.304

2.  Electrocardiographic Characterization of Cardiac Hypertrophy in Mice that Overexpress the ErbB2 Receptor Tyrosine Kinase.

Authors:  Polina Sysa-Shah; Lars L Sørensen; M Roselle Abraham; Kathleen L Gabrielson
Journal:  Comp Med       Date:  2015-08       Impact factor: 0.982

Review 3.  Is genotype determination useful in predicting the clinical phenotype in lysosomal storage diseases?

Authors:  I Maire
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

Review 4.  Pompe disease gene therapy.

Authors:  Barry J Byrne; Darin J Falk; Christina A Pacak; Sushrusha Nayak; Roland W Herzog; Melissa E Elder; Shelley W Collins; Thomas J Conlon; Nathalie Clement; Brian D Cleaver; Denise A Cloutier; Stacy L Porvasnik; Saleem Islam; Mai K Elmallah; Anatole Martin; Barbara K Smith; David D Fuller; Lee Ann Lawson; Cathryn S Mah
Journal:  Hum Mol Genet       Date:  2011-04-25       Impact factor: 6.150

Review 5.  An emerging phenotype of central nervous system involvement in Pompe disease: from bench to bedside and beyond.

Authors:  Aditi Korlimarla; Jeong-A Lim; Priya S Kishnani; Baodong Sun
Journal:  Ann Transl Med       Date:  2019-07

6.  Induction of tolerance to a recombinant human enzyme, acid alpha-glucosidase, in enzyme deficient knockout mice.

Authors:  Nina Raben; Kanneboyina Nagaraju; Alicia Lee; Nina Lu; Yesenia Rivera; Tejas Jatkar; John J Hopwood; Paul H Plotz
Journal:  Transgenic Res       Date:  2003-04       Impact factor: 2.788

7.  Correction of glycogenosis type 2 by muscle-specific lentiviral vector.

Authors:  Emmanuel Richard; Gaëlle Douillard-Guilloux; Lionel Batista; Catherine Caillaud
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-09-23       Impact factor: 2.416

8.  Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe disease.

Authors:  Gaelle Douillard-Guilloux; Nina Raben; Shoichi Takikita; Arnaud Ferry; Alban Vignaud; Isabelle Guillet-Deniau; Maryline Favier; Beth L Thurberg; Peter J Roach; Catherine Caillaud; Emmanuel Richard
Journal:  Hum Mol Genet       Date:  2009-12-03       Impact factor: 6.150

9.  A bacterial glycosidase enables mannose-6-phosphate modification and improved cellular uptake of yeast-produced recombinant human lysosomal enzymes.

Authors:  Petra Tiels; Ekaterina Baranova; Kathleen Piens; Charlotte De Visscher; Gwenda Pynaert; Wim Nerinckx; Jan Stout; Franck Fudalej; Paco Hulpiau; Simon Tännler; Steven Geysens; Annelies Van Hecke; Albena Valevska; Wouter Vervecken; Han Remaut; Nico Callewaert
Journal:  Nat Biotechnol       Date:  2012-11-18       Impact factor: 54.908

10.  Dysfunctional glycogen storage in a mouse model of alpha1-antitrypsin deficiency.

Authors:  Ralf H Hubner; Philip L Leopold; Maija Kiuru; Bishnu P De; Anja Krause; Ronald G Crystal
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-07       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.